|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 53.62 USD | -3.87% |
|
-6.78% | +79.87% |
| 08-03 | TG Therapeutics, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-03 | TG Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 7.61B 6.76B 6.32B 5.76B 10.84B 732B 10.99B 76.43B 29.59B 373B 28.56B 27.94B 1,198B | P/E 2026 * |
55.1x | P/E 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise Value | 7.77B 6.91B 6.46B 5.88B 11.08B 749B 11.23B 78.13B 30.24B 381B 29.19B 28.56B 1,224B | EV / Sales 2026 * |
8.1x | EV / Sales 2027 * | 5.5x |
| Free-Float |
88.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TGTX | Delayed | |
CBOE
| TGTX | Real-time | |
|
London S.E.
| 0VGI | Delayed | |
|
Tradegate
| NKB2 | Real-time | |
|
Deutsche Boerse AG
| NKB2 | Delayed | |
|
Börse Stuttgart
| NKB2 | Delayed | |
|
Boerse Muenchen
| NKB2 | Real-time | |
|
Berne S.E.
| NKB2 | End-of-day quote | |
|
Borsa Italiana
| 1TGTX | End-of-day quote |
Last Transcript: TG Therapeutics, Inc.
| 1 day | -3.87% | ||
| 1 week | -6.78% | ||
| Current month | -3.87% | ||
| 1 month | -4.40% | ||
| 3 months | +0.19% | ||
| 6 months | +59.68% | ||
| Current year | +79.87% |
| 1 week | 53.59 |  | 57.66 |
| 1 month | 52.5 | | 58.92 |
| Current year | 26.76 | | 59.3 |
| 1 year | 26.76 | | 59.3 |
| 3 years | 6.46 | | 59.3 |
| 5 years | 3.48 | | 59.3 |
| 10 years | 3.32 | | 59.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 60 | 2011-12-28 |
Sean Power
DFI | Director of Finance/CFO | 44 | 2011-12-28 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 2011-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CHM | Chairman | 60 | 2011-12-28 |
Laurence Charney
BRD | Director/Board Member | 79 | 2012-02-29 |
Yann Echelard
BRD | Director/Board Member | 62 | 2012-11-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 | Sell | Director | -5,000 | 0.0033% | ||
| 8/7/26 | Don | Director | -950 | 0.0006% | ||
| 1/28/26 | Don | Director | 43,197 | 0.0272% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.87% | -6.78% | +46.66% | +541.39% | 7.61B | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | |
| -0.27% | -3.41% | +22.41% | +40.29% | 336B | |
| -0.08% | -1.57% | +13.36% | +26.29% | 270B | |
| -0.43% | -4.46% | -3.71% | +9.52% | 247B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | |
| Average | -1.05% | -2.38% | +29.21% | +106.01% | 372.58B | |
| Weighted average by Cap. | -0.53% | -2.12% | +30.40% | +70.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 960M 853M 798M 727M 1.37B 92.45B 1.39B 9.65B 3.74B 47.09B 3.61B 3.53B 151B | 1.32B 1.17B 1.1B 998M 1.88B 127B 1.91B 13.25B 5.13B 64.68B 4.95B 4.85B 208B |
| Net income | 161M 143M 134M 122M 229M 15.48B 232M 1.62B 625M 7.88B 604M 591M 25.32B | 445M 395M 369M 337M 634M 42.81B 642M 4.47B 1.73B 21.8B 1.67B 1.63B 70.03B |
| Net Debt | 169M 150M 140M 128M 241M 16.27B 244M 1.7B 657M 8.29B 635M 621M 26.62B | -348M -309M -289M -263M -496M -33.51B -503M -3.5B -1.35B -17.06B -1.31B -1.28B -54.81B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | US$53.62 | -3.87% | 2,122,670 |
| 26-09-30 | US$55.78 | -0.73% | 1,908,214 |
| 26-09-29 | US$56.19 | 0.00% | 1,608,131 |
| 26-09-28 | US$56.19 | -2.16% | 1,442,422 |
| 26-09-25 | US$57.43 | -0.16% | 1,309,402 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TGTX Stock
Select your edition
All financial news and data tailored to specific country editions
